(1)
Dalla Chiesa, M.; Passalacqua, R.; Michiara, et al., M. Tamoxifen Vs Tamoxifen Plus 13-Cis-Retinoic Acid Vs Tamoxifen Plus Interferon a–2a As First-Line Endocrine Treatments in Advanced Breast Cancer: Updated Results of a Phase II, Prospective, Randomised Multicentre Trial. Acta Biomed 2007, 78 (3), 204-209.